Clinical Trial

Type 2 Diabetes and Associated Factors in Mexico

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational cross-sectional multicenter study is to identify clinical, lifestyle, metabolic, inflammatory, and genetic factors associated with glycemic control and complications of Type 2 Diabetes (T2D) in adult patients in Mexico. The main questions it aims to answer are: Which molecular and clinical factors are associated with poor glycemic control (HbA1c \> 7%)? Which factors are linked to the presence of diabetic nephropathy (GFR \< 60 mL/min/1.73 m²)? Participants: Provide informed consent and clinical history. Undergo a clinical and physical evaluation (including six-minute walk test). Complete lifestyle, dietary, and therapeutic adherence questionnaires. Provide blood samples for biochemical, inflammatory, and transcriptomic (RNA-Seq) analysis. Researchers integrate clinical, biochemical, and transcriptomic data using statistical modeling to identify a characteristic molecular fingerprint of poor metabolic control and diabetes-related complications.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-18.
Trial Details
NCT Number NCT07248891
Lead Sponsor Coordinación de Investigación en Salud, Mexico
Conditions Diabetes Mellitus, Type 2, Chronic Kidney Disease, Diabetic Nephropathy
Enrollment 1,000 participants
Start Date 2025-04-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-04